Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. - Wikidata - awgldk - TriplyDB

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

http://www.wikidata.org/entity/Q36385482

about

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiation Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiation Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera.Biology and disease associations of Epstein-Barr virus.Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China Complement-fixing antigens in Burkitt lymphoma cell lines EB virus in relation to tumours.The EB virus in relation to infectious mononucleosis.From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Host responses to Epstein-Barr virus and cytomegalovirus infection in leprosy Effects of dialyzable transfer factor in patients with breast cancer.Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.Detection of antibody to autologous human leukemia cells by immune adherence assays.Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins.Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.Characterization of a new dual-targeting fully human antibody with potent antitumor activity against nasopharyngeal carcinoma.DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.Infections and immune factors in cancer: the role of epidemiology.Immunodiagnostic tests for cancer.Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells.The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.Pleiotropic expression of Epstein--Barr virus DNA in human epithelial cells.Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.Immune regulation in Epstein-Barr virus-associated diseases Immunological studies on Burkitt's lymphoma.Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.

P2860

Q24632165-5531A12D-36BE-4C53-B47F-CBDE6C381183 Q26823898-969FB4D5-685E-4307-9C9C-16FEE8200C13 Q26853527-5952693D-C0C8-4C80-AC8E-24F5532D2351 Q27010624-E9FE5CB8-E8B4-4F09-93C5-F01736649D4E Q30442776-96EE97E7-E655-4614-8248-A490C935FF99 Q33772230-F5A41D15-7C12-4163-BB40-149788D04037 Q33973347-EEF76E5D-D293-4E3F-AC73-2CEAD3C6386B Q34081186-38A9F7EA-7A5D-4D0A-944D-F16F56E17AAC Q34172407-599BEE70-AD8A-4E2C-9E7E-0A1BD1293DE6 Q34303146-4D74D460-A48A-40A9-A1B3-4C208628A99B Q34303153-2B32C337-54BB-43F4-9B6A-0335C165AE32 Q34397565-0164FABE-77E3-4E62-8520-29D967DF1A84 Q34483687-593FEAFE-5D14-44F4-A7F1-C60EA819BD47 Q34487494-BCD5DDB3-30E6-49EE-8111-30D6CF7FAEED Q34698721-5DCBF354-9F6B-4DE1-80C3-F250521DE7ED Q34841962-B2E35942-186D-47B8-A9E6-AA7D9E88E1E1 Q35058290-F489C18D-AB53-4559-94EE-F945C6210A41 Q35140045-731A008A-D5D8-4FA9-9AB2-474F038D2822 Q35239753-C3EC9C5A-A183-4F4D-AA87-6A941FE0211B Q35454581-0C650837-0574-40AC-A751-741C8C1AE711 Q35624112-0DE704A3-1E76-4DC2-AC99-EBAEA3DB31C2 Q35868023-6B2DEF7D-173E-437B-BAB2-2D887E0F1AAE Q35926370-658FD289-7FEF-48EF-B86E-76104CD77656 Q35973977-6872A242-D949-4B22-9711-AF353A0B9FF4 Q36027817-F007E9BF-F225-4EE3-8EBD-7879DE7B810C Q36047055-A7A2046E-E55C-46D9-91E8-BD2CE73A42D5 Q36069079-0D0D6DBD-B4D8-4562-91E8-5939B57F468A Q36195236-CDA57AF6-60DE-442B-899C-757F6EF17AE6 Q36269631-DF8C0979-D09A-4C28-95BD-49D5E24A3777 Q36370677-FB1BB008-4374-45DE-93E4-553D0912C209 Q36412130-90D1A2D5-0C82-437D-8CBF-DF25C25C7B93 Q36474978-951EDC1B-8F41-49E2-A6E1-C7B3557E5CCB Q36539838-649E14C8-DABF-4817-A1BC-D0922D355F0A Q36609904-BB571D94-452B-4B82-B12B-3ABBA52B080E Q36669953-DE3A15CE-74DE-496B-9A5C-09918959DA9D Q36771324-4435BD80-E3C2-4DBC-82D3-20E5CF377818 Q36839720-8BCE5175-D52C-48C1-A8B5-97FE96ECBCF0 Q36855331-B22D88C5-537A-44B5-8733-BCC48EF82A26 Q36904686-D7C30D08-EE9A-47BB-9532-1B3F9549FCA2 Q36991541-717558F5-F474-4CB4-A037-596B80CECDC9

P2860

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

http://www.wikidata.org/entity/Q36385482

description

1966 nî lūn-bûn

@nan

1966年の論文

@ja

1966年学术文章

@wuu

1966年学术文章

@zh-cn

1966年学术文章

@zh-hans

1966年学术文章

@zh-my

1966年学术文章

@zh-sg

1966年學術文章

@yue

1966年學術文章

@zh

1966年學術文章

@zh-hant

name

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@ast

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@en

type

label

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@ast

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@en

prefLabel

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@ast

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@en

P1433

Q36385482-862597D8-5A50-4159-A626-03E5CC60BBD1

P1476

Q36385482-55184340-78DD-497F-AA62-6111F79013BF

P2093

Q36385482-0D90D030-D7CE-45C6-BAD9-2F180032FB20

Q36385482-36BDA48D-AEF2-4D7E-A181-BC8025775E48

Q36385482-5C7BDAC4-3D89-4084-A893-502284CD9164

Q36385482-65ADE2BE-6F82-41DE-97C3-E4C364595F20

Q36385482-892710A6-D5FE-40D3-9AC9-0A0744BB0E97

Q36385482-D3DBB974-45DB-4002-94F4-8F94D848D26C

Q36385482-EBC814EB-838B-43DA-A1BA-D6E3A7D544D9

P2860

Q36385482-183B31B0-236B-4026-BBD5-559CDBB44505

Q36385482-23540362-2928-4086-82F4-2D28A4F9A2D8

Q36385482-24AE8887-EAA3-4B5E-8E76-1BC3E6687580

Q36385482-2A431D12-5FFB-43E7-8D9C-8D417E47A46D

Q36385482-2E5552F5-A674-4246-8AE2-5B37A837BF4B

Q36385482-32DE1A0D-3655-4160-9DDE-CBDCDC58BA28

Q36385482-451F9DD0-7892-4F27-A6B3-64E15E08EC81

Q36385482-4D1CE47D-9007-4EB4-9A48-2909349D441D

Q36385482-59A0B89B-85F4-4A1F-9B34-377F979542B3

Q36385482-7FDEAA65-2BEE-4C43-8A1A-197BD0162C40

P304

Q36385482-D3FD1E1C-8DF3-4E12-AAD0-3837FB92456C

P31

Q36385482-0E193D37-1E3E-4736-A952-985D4A307FC7

P356

Q36385482-4AD0B68C-88F2-41F5-8DF3-E185D7138BD4

P407

Q36385482-F119BCA8-E151-4077-8F78-3F44F2FA93E5

P433

Q36385482-FAC5B141-694A-41C3-9702-F0864797A992

P478

Q36385482-25805A06-B7AB-4263-8908-E5552DACBD6B

P577

Q36385482-0E64929D-337A-4C06-8DCB-71063003DA97

P5875

Q36385482-473EDB16-3D6A-48A4-8A09-793B95F4BE89

P698

Q36385482-ADDFED61-CC59-469C-84F3-C2DCC56B1722

P921

Q36385482-71395C34-038B-4CFC-A3F6-E88CC607531C

Q36385482-D0CB0162-D467-4F87-AF2B-1634A164A43D

P932

Q36385482-4276080A-79CF-4B24-A543-75F724AED9AA

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Precipitating antibody in huma ...... ured burkitt's lymphoma cells.

@en

P2093

Boyse EA

http://www.w3.org/2001/XMLSchema#string

Clifford P

http://www.w3.org/2001/XMLSchema#string

Geering G

http://www.w3.org/2001/XMLSchema#string

Harven ED

http://www.w3.org/2001/XMLSchema#string

Oettgen HF

http://www.w3.org/2001/XMLSchema#string

Old LJ

http://www.w3.org/2001/XMLSchema#string

Williamson B

http://www.w3.org/2001/XMLSchema#string

P2860

MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

Isolation of a Reovirus from a Case of Burkitt's Lymphoma

Further isolations of reovirus type 3 from cases of Burkitt's lymphoma

A sarcoma involving the jaws in African children

Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

UNIDENTIFIED, FILTRABLE AGENTS ISOLATED FROM AFRICAN CHILDREN WITH MALIGNANT LYMPHOMAS.

Immunofluorescence in cells derived from Burkitt's lymphoma.

Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias.

Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction.

P304

1699-1704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.56.6.1699

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

1966-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7189552

http://www.w3.org/2001/XMLSchema#string

P698

16591407

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

P932

220158

http://www.w3.org/2001/XMLSchema#string